Clinical trial

Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients…

NCT00247715 · Radboud University Medical Center, Other · Completed

Key facts

NCT number NCT00247715
Title Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)
Official title Comparison of an Antacid/H2-Receptor Antagonist/Proton Pump Inhibitor Versus a Proton Pump Inhibitor/H2-Receptor Antagonist/Antacid Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)
Lead sponsor Radboud University Medical Center, Other
Collaborators ZonMw: The Netherlands Organisation for Health Research and Development
Status Completed
Study type Interventional
Conditions Dyspepsia, Gastrointestinal Diseases
Intervention type Drug
Interventions algeldrate/magnesium oxide, ranitidine, pantoprazole
Enrollment 664
Start date Oct 1, 2003
Completion Jan 1, 2007
First posted Nov 2, 2005
Last update posted Aug 29, 2007
Countries Netherlands

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies